rs113488022
|
|
T |
0.900 |
CausalMutation |
CLINVAR |
|
|
|
rs121913348
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs121913364
|
|
C |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs180177032
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs180177033
|
|
C |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs121913348
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
|
12198537 |
2002 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
|
12198537 |
2002 |
rs113488022
|
|
|
0.900 |
GeneticVariation |
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
rs180177032
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
rs180177033
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
rs113488022
|
|
|
0.900 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs180177032
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs180177033
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs113488022
|
|
|
0.900 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs121913348
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.
|
21917714 |
2011 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.
|
21917714 |
2011 |
rs180177032
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs180177033
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs113488022
|
|
|
0.900 |
GeneticVariation |
UNIPROT |
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
|
22855150 |
2012 |
rs113488022
|
|
|
0.900 |
GeneticVariation |
UNIPROT |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
|
23012255 |
2012 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
|
22855150 |
2012 |
rs121913364
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
|
23012255 |
2012 |